PHR
Phreesia, Inc.
NYSE · Healthcare · Medical - Healthcare Information Services · US
$10.85
−2.30%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 507.8M | 480.6M | 419.8M | 356.3M | 280.9M |
| Cost of Revenue | 151.1M | 154.1M | 134.9M | 124.0M | 109.3M |
| Gross Profit | 356.7M | 326.5M | 284.9M | 232.3M | 171.6M |
| Operating Expenses | |||||
| R&D Expense | 116.3M | 121.5M | 117.4M | 112.3M | 91.2M |
| SG&A Expense | 176.9M | 180.1M | 197.7M | 226.9M | 231.6M |
| General & Admin Expense | 79.3M | 79.9M | 76.6M | 79.9M | 80.4M |
| Selling & Marketing Expense | 97.6M | 100.2M | 121.1M | 147.0M | 151.3M |
| Other Expenses | 16.8M | 31.5M | 27.9M | 29.5M | 25.3M |
| Total Operating Expenses | 310.0M | 333.1M | 343.0M | 368.8M | 348.2M |
| Cost and Expenses | 461.1M | 487.2M | 477.9M | 492.8M | 457.5M |
| Operating Income (EBIT) | 13.9M | (6.6M) | (58.1M) | (136.5M) | (176.6M) |
| Non-Operating | |||||
| Interest Income | 2.0M | 2.2M | 2.7M | 4.1M | 2.5M |
| Interest Expense | 10.7M | 7.0M | 2.3M | 1.9M | 1.4M |
| Net Interest Income | (8.6M) | (4.8M) | 330.0K | 2.2M | 1.1M |
| Other Non-Op Income/Expense | (5.6M) | (2.3M) | 2.3M | 1.1M | 889.0K |
| Non-Operating Income (excl Interest) | (2.8M) | (4.6M) | (4.6M) | (3.0M) | (2.3M) |
| EBT (Pre-Tax Income) | 2.8M | (8.9M) | (55.8M) | (135.3M) | (175.7M) |
| Income Tax Expense | (10.3M) | (11.2M) | 2.7M | 1.5M | 483.0K |
| Bottom Line | |||||
| Net Income | 13.1M | 2.3M | (58.5M) | (136.9M) | (176.1M) |
| Earnings from Cont. Ops | 13.1M | 2.3M | (58.5M) | (136.9M) | (176.1M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 13.1M | 2.3M | (58.5M) | (136.9M) | (176.1M) |
| Per Share | |||||
| Basic EPS | $0.17 | $0.04 | ($1.02) | ($2.51) | ($3.36) |
| Diluted EPS | $0.17 | $0.04 | ($1.02) | ($2.51) | ($3.36) |
| Revenue Per Share | $8.21 | $8.04 | $7.29 | $6.53 | $5.36 |
| Shares | |||||
| Basic Shares Outstanding | 61.9M | 59.7M | 57.6M | 54.6M | 52.4M |
| Diluted Shares Outstanding | 62.5M | 61.5M | 57.6M | 54.6M | 52.4M |
| Profitability Metrics | |||||
| EBITDA | 54.0M | 29.5M | (25.6M) | (102.9M) | (145.5M) |
| D&A | 37.3M | 31.5M | 27.9M | 30.5M | 28.8M |
| EBIT | 16.7M | (2.0M) | (53.5M) | (133.5M) | (174.3M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jul 1, 2026